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The fraction that contained most of the antigenic activity was then used to locate the zymogen in the pancreas by using a direct immunofluorescence technique on tissue sections.
Antibody to rat submandibular kallikrein was labelled with tetramethylRhodamine isothiocyanate. The conjugate was purified by gel filtration on Sephadex G-50 and by anionic-exchange chromatography by using the method of Brandtzaeg (1973~). The selected fractions had an absorbance ratio ( A 2 8 0 / A 5 , 5 ) of 2.4 and were used at an immunoglobulin concentration of 0.6mg/ml as established by performance testing. Samples of the conjugate were adsorbed with mouse liver powder to decrease non-specific background staining. For the same purpose dilutions of the conjugate were made in 12% bovine serum albumin, and the tissue sections were preincubated with bovine serum albumin for 30min (Brandtzaeg, 19736) . Conjugate incubation, washing and mounting of tissue sections were performed as described by Brandtzaeg (1973h) . Immunological specificity of the fluorescence reaction was controlled by adsorption of the conjugate with purified rat submandibular kallikrein or the partially pure rat pancreatic prekallikrein.
Fluorescence microscopy was carried out with a Leitz Ortholux microscope equipped with a Ploem-type vertical illuminator. Conditions for narrow-band excitation and selective filtration of Rhodamine fluorescence (Brandtzaeg, 19736) were used.
Prekallikrein was located in the acini of the rat pancreas. It may therefore be hypothesized that pancreatic kallikrein has its main function outside the gland and, upon secretion into the duodenum, may act upon the gut epithelium. Liver cytosol of rats contains two protein fractions that bind bilirubin with high affinity. One, of mol.wt. 46000, is apparently identical with ligandin (Litwack et al., 1971) a protein that has also been known as aminoazodye-binding protein B (Ketterer et al., 1967) or Y-protein (Levi et al., 1969) , and that is identical with glutathione S-transferase B (Habig et al., 1974). The other, of mol.wt. 14000, is probably identical with aminoazodye-binding protein A (protein A) (Ketterer et al., 1967 (Ketterer et al., , 1976 or Z-protein (Levi et al., 1969) . Besides bilirubin (Meuwissen et al., 1972; Tipping et al., 1976a) , a number of other substances both endogenous and exogenous have been shown to possess varying affinities for either one or both of these proteins (Tipping et al., 1976b,c; Ketterer et al., 1976) . The binding proteins are of importance for the cellular transport of their ligands. In the case of bilirubin these proteins may be (Meuwissen et al., 1977) . An important requirement for assigning such properties to these liver proteins is high binding activity and, in the case of hepatic uptake, binding activity at least as high as that of albumin in plasma. Binding affinity for bilirubin is, however, very labile and diminishes rapidly upon fractionation of the isolated cytosol. The highest values have been obtained with fresh cytosol (Meuwissen & Ketterer, 1975) when affinity for bilirubin is sufficient to account for the passive uptake of pigment by the liver cell. The loss of binding activity mainly involves ligandin. However, ligandin retains its activity in separations involving moving boundary rather than zonal centrifugation (Meuwissen etal., 1977) . This led us to postulate that in cytosol an endogenous factor of low molecular weight is required t o maintain the binding properties of this protein. A possible candidate for this hypothetical factor is GSH (reduced glutathione), since GSH has a binding site on ligandin and the concentration of GSH in the liver is so high (approx. 5 m~) that ligandin will be almost totally GSH-bound in the native cytosol (Tippingetal., 1976h). We have therefore investigated the effects of GSH on the binding of bilirubin by protein components of rat liver cytosol during a zone fractionation.
Gel filtration of Gunn rat liver cytosol by using Sephadex G-100 yields three bilirubin-containing fractions. The first is eluted with the void volume and consists either of colloidal bilirubin or of bilirubin associated with small microsomal fragments. The second and third fractions coincide with ligandin and protein A respectively. Total bilirubin recovery is only 50% of which the largest part is found at the void volume. If, on the other hand, gel filtration is carried out in a GSH-containing buffer the recovery of bilirubin is complete, none is found at the void volume and the fraction corresponding to ligandin contains 60-80% of the pigment (see Table I ). Gel filtration of mixtures of Gunn-rat liver cytosol and Wistar-rat plasma was also conducted. Without addition of GSH protein A carries the greatest amount of total bilirubin, albumin less and ligandin the least. On the other hand, in the presence of GSH, ligandin binds the most bilirubin and albumin the least. In neither of these systems is bilirubin found at the void volume (see Table 1 ).
The binding activity of the ligandin fraction for bilirubin is thus strongly influenced by GSH. Albumin and the protein A fraction might not be affected, and, if so, because of competition with ligandin of decreased affinity, they will carry comparatively more of the ligand. These results also prove that cytosol proteins bind bilirubin more strongly than does albumin. The mechanism whereby GSH exerts its influence on the bilirubin-binding activity of the ligandin fraction has not yet been elucidated. It might be a specific effect of GSH associated with its binding by ligandin or it might be a general effect of mercaptans, as suggested by Ketley et al. (1975) Dextran T40 (Pharmacia, London W.5, U.K.) (2.5g) was activated with CNBr by using the technique of Larsson 8c Mosbach (1974) . When the reaction was judged complete 0.1 M-HCI was added until the pH reached 8.5. Aqueousp-phenylenediamine (5mI, 0.45mmol), pH8.5, was added to the activated dextran and left overnight at room temperature while gassing with N2. As an extra precaution the reaction was shielded from light. The solution was poured into 15~01. of ethanol (4"C), the precipitate was collected by filtration, washed with ethanol and diethyl ether and the dextran derivative stored dry in a vacuum desiccator until required. ATP (82.5pmol) was dissolved in 2ml of 50m~-citrate buffer, pH6.0. To this solution was added 3 ml of aq. 25 % (w/v) glutaraldehyde and left at room temperature for 30min.
The ATP derivative was precipitated in 15vol. of ethanol (4°C) and collected by centrifugation at 4OOOOg for 15min. The precipitate was redissolved in 15ml of 5 0 m~-citrate buffer, pH6.0, containing 0.5g of dextran derivative. After 30min the pH was adjusted to pH9.0 with ~M -N~O H , and approx. 0.2g of solid potassium borohydride added to reduce the Schiff bases. The solution was made up to 20 ml and stored at -30°C.
To remove the unbound ATP 0.5 ml samples were chromatographed on Sephadex G-25 (fine grade) (0.5cmx46.0cm) in 25m~-Tris/HCI buffer, pH7.5, at a flow rate of 7.5 ml/h. The addition of 1 M-NaCI to the buffer made no difference to the separation.
The amount of ATP bound to the soluble dextran was measured by three independent methods ( Table 1) . Total phosphorus was measured by the method of Bartlett (1959) and the hexokinase assay performed by the method of Woodward (1971) . The u.v.-absorption spectrum showed a A, , , , , . of 266nm, which is typical of "Qubstituted nucleotides.
Coenzyme activity was observed towards hexokinase (EC 2.7.1. I), glycerol kinase (EC 2.7.1.30) and pyruvate kinase (EC 2.7.1.40).
No attempt has been made to optimize the method. Preliminary results suggest that the method will be applicable to the immobilization of polynucleotides, RNA and DNA. Also, binding may be significantly increased by altering the pH of the reaction. The VOl. 5
